vs
Dime Community Bancshares, Inc.（DCOM）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Dime Community Bancshares, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$123.8M vs $75.5M），Dime Community Bancshares, Inc.同比增速更快（3040.1% vs 27.7%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 22.9%）
戴姆社区银行前身是威廉斯堡戴姆储蓄银行，是受FDIC保险的本土银行，1864年创立，最初扎根于纽约布鲁克林威廉斯堡社区，至今在该区域仍保有强劲的市场影响力，目前总部设于纽约州霍波格，2021年已完成与布里奇 Bancorp 的合并。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
DCOM vs PBYI — 直观对比
营收规模更大
DCOM
是对方的1.6倍
$75.5M
营收增速更快
DCOM
高出3012.4%
27.7%
两年增速更快
PBYI
近两年复合增速
22.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $123.8M | $75.5M |
| 净利润 | — | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 38.6% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 3040.1% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.68 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DCOMPBYI
| Q4 25 | $123.8M | $75.5M | ||
| Q3 25 | $115.6M | $54.5M | ||
| Q2 25 | $109.7M | $52.4M | ||
| Q1 25 | $103.8M | $46.0M | ||
| Q4 24 | $3.9M | $59.1M | ||
| Q3 24 | $87.6M | $80.5M | ||
| Q2 24 | $87.3M | $47.1M | ||
| Q1 24 | $82.0M | $43.8M |
净利润DCOMPBYI
| Q4 25 | — | — | ||
| Q3 25 | $27.7M | $8.8M | ||
| Q2 25 | $29.7M | $5.9M | ||
| Q1 25 | $21.5M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $13.3M | $20.3M | ||
| Q2 24 | $18.5M | $-4.5M | ||
| Q1 24 | $17.7M | $-4.8M |
毛利率DCOMPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率DCOMPBYI
| Q4 25 | 38.6% | 22.7% | ||
| Q3 25 | 34.7% | 17.6% | ||
| Q2 25 | 36.6% | 12.7% | ||
| Q1 25 | 27.6% | 8.7% | ||
| Q4 24 | -433.6% | 22.6% | ||
| Q3 24 | 20.8% | 27.4% | ||
| Q2 24 | 29.8% | -4.6% | ||
| Q1 24 | 29.6% | -5.3% |
净利率DCOMPBYI
| Q4 25 | — | — | ||
| Q3 25 | 23.9% | 16.2% | ||
| Q2 25 | 27.1% | 11.2% | ||
| Q1 25 | 20.7% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 15.2% | 25.2% | ||
| Q2 24 | 21.2% | -9.6% | ||
| Q1 24 | 21.6% | -11.0% |
每股收益（稀释后）DCOMPBYI
| Q4 25 | $0.68 | $0.26 | ||
| Q3 25 | $0.59 | $0.17 | ||
| Q2 25 | $0.64 | $0.12 | ||
| Q1 25 | $0.45 | $0.06 | ||
| Q4 24 | $-0.58 | $0.40 | ||
| Q3 24 | $0.29 | $0.41 | ||
| Q2 24 | $0.43 | $-0.09 | ||
| Q1 24 | $0.41 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $1.5B | $130.3M |
| 总资产 | $15.3B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资DCOMPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务DCOMPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益DCOMPBYI
| Q4 25 | $1.5B | $130.3M | ||
| Q3 25 | $1.5B | $115.3M | ||
| Q2 25 | $1.4B | $104.7M | ||
| Q1 25 | $1.4B | $97.1M | ||
| Q4 24 | $1.4B | $92.1M | ||
| Q3 24 | $1.3B | $71.1M | ||
| Q2 24 | $1.3B | $48.5M | ||
| Q1 24 | $1.2B | $51.0M |
总资产DCOMPBYI
| Q4 25 | $15.3B | $216.3M | ||
| Q3 25 | $14.5B | $202.9M | ||
| Q2 25 | $14.2B | $194.9M | ||
| Q1 25 | $14.1B | $196.2M | ||
| Q4 24 | $14.4B | $213.3M | ||
| Q3 24 | $13.7B | $220.7M | ||
| Q2 24 | $13.5B | $205.0M | ||
| Q1 24 | $13.5B | $214.1M |
负债/权益比DCOMPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $186.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流DCOMPBYI
| Q4 25 | $186.6M | $14.4M | ||
| Q3 25 | $52.1M | $9.7M | ||
| Q2 25 | $23.1M | $14.1M | ||
| Q1 25 | $65.4M | $3.6M | ||
| Q4 24 | $99.1M | $15.6M | ||
| Q3 24 | $-33.3M | $11.0M | ||
| Q2 24 | $12.6M | $1.0M | ||
| Q1 24 | $30.7M | $11.2M |
自由现金流DCOMPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | $51.2M | $9.7M | ||
| Q2 25 | $20.4M | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $-34.1M | $11.0M | ||
| Q2 24 | $9.2M | $1.0M | ||
| Q1 24 | — | — |
自由现金流率DCOMPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | 44.3% | 17.7% | ||
| Q2 25 | 18.6% | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | -38.9% | 13.7% | ||
| Q2 24 | 10.5% | 2.1% | ||
| Q1 24 | — | — |
资本支出强度DCOMPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.7% | 0.0% | ||
| Q2 25 | 2.4% | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 0.9% | 0.0% | ||
| Q2 24 | 3.9% | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率DCOMPBYI
| Q4 25 | — | — | ||
| Q3 25 | 1.88× | 1.10× | ||
| Q2 25 | 0.78× | 2.41× | ||
| Q1 25 | 3.05× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -2.50× | 0.54× | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 1.74× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
